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Abstract
The aim of this study was to isolate and characterize porcine amniotic fluid-derived multipotent stem cells (pAF-MSC). The
porcine amniotic fluid (AF) from the amniotic cavity of pregnant gilts in the early stages of gestation (at E35) was collected
and centrifuged for 5–10 min at 400 g to pellet cells. The primary culture of AF showed the multiple cell types, including
the epithelial-like cells and fibroblast-like cells. By culturing in AMM medium for 6 to 8 days, the epithelial-like cells
disappeared and the remaining cells presented the fibroblastoid morphology. The doubling time of pAF-MSCs was about
34.6 h, and the cells had been continually cultured over 60 passages in vitro. The flow cytometry results showed that pAF-
MSCs were positive for CD44, CD117 and CD166, but negative for CD34, CD45 and CD54. Meanwhile, pAF-MSCs expressed
ES cell markers, such as Oct4, Nanog, SSEA4, Tra-1-60 and Tra-1-81. The ratio of CD117
+ CD44
+ cells accounted for 98% of
pAF-MSCs population. Three germ layer markers, including FGF5 (ectodermal marker), AFP (endodermal marker) and Bra
(mesodermal marker), were detected in embryoid bodies derived from pAF-MSCs. Under the different induction
conditions, the pAF-MSCs were capable of differentiating into neurocytes, adipocytes and beating cardiomyocytes.
Furthermore, the pAF-MSCs didn’t form teratoma when injected into immunodeficiency mice. These optimal features of
pAF-MSCs provide an excellent alternative stem cell resource for potential cell therapy in regenerative medicine and
transgenic animals.
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Introduction
Amniotic fluid (AF) is composed of normal embryonic or fetal
chipping cells derived from the three germ layers (ectoderm,
endoderm and mesoderm) [1,2]. Therefore, it possesses the natural
precursors of all differentiation lineages. Recently, AF has been
used as a source of human mesenchymal stem cells (hMSCs) that
express the specific markers, such as CD90, CD105, CD73 and
CD166 [3,4,5,6]. Meanwhile, Oct4-expressing cells are present in
human amniotic fluid [7], indicating that human amniotic fluid
may be a new source of pluripotent stem cells without any ethical
concerns associated with human embryonic stem cells (hES cells)
research [8,9].
The cells isolated from human amniotic fluid were first named
human amniotic fluid stem cells (hAFSCs) in 2007 [4]. Over 90%
of hAFSCs express Oct4 (the specific marker of ES cells). Besides,
CD117 is also used as a critical marker for identifying AFS cells
[1]. The hAFSCs have self-renewal capability and multi-lineage
differentiation potential similar to ES cells. It has been reported
that human AFS cells could differentiate into multiple cell lineages,
including adipocytes [5], osteoblasts [4], chondrocytes [10],
cardiomyocytes [1,11,12,13], endothelial cells [4], neurocytes
[14], hepatocytes [4] and renal cells [11]. However, unlike ES
cells, the hAFSCs don’t form teratoma when injected subcutane-
ously into nude mice [7]. Thus, the AFS may be an intermediate
type of cells between ES cells and adult stem cells.
Pig is a main domestic animal and has many biophysical and
biochemical similarity to human beings. The use of pig models for
pre-clinical testing is well established and the availability of
embryonic stem cells may open the way to pre-clinical
experimentation for any kind of cell therapy. However, thus far,
the stable embryonic stem cell lines have not yet been generated
from pig embryos, but rather obtained by normal fertilization or
by parthenogenetic activation [15]. The iPS technology has been
used to generate pig iPS cells that presented the defining features
similar to either human or mouse ES cells [16,17]. Although the
chimera pig derived from pig iPS cells has been reported [18],
several important issues remain to be addressed, such as the low
efficacy of generating fully reprogrammed pig iPS cell line and the
safety of iPS cells. Therefore, the alternative stem cells such as
porcine amniotic fluid mesenchymal stem cells (pAF-MSCs) may
provide a novel and convenient cell resource, which can be used
for transgenic animal research and regeneration medicine.
In this paper, we characterized pAF-MSCs and demonstrated
the multipotency of pAF-MSCs. Our study revealed that these
cells were similar to hAFSCs and could differentiate into cell
derivatives of the three germ layers, especially the beating
cardiomyocytes.
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The pAF-MSCs isolated from porcine amniotic fluid
The porcine AF was collected from amniotic cavity in the early
stage gestation of porcine fetus (at E35, Fig. 1A). After 3 days of in
vitro culture, both fibroblast-like cells and epithelioid cells
appeared. For 2 to 3 passages, most cells exhibited fibroblast-like
phonotype (Fig. 1B), and occasionally, some ES cell-like colonies
were observed and these colonies were positive for AP staining
(Fig. 1C). In early culture passages (0 to 3) due to the existing
mixed cell populations, the cell growth rate was slow, which took
3–4 days to passage once. After 4–5 passages, the cell populations
exhibited the uniform fibroblast-like morphology, and the growth
rate of pAF-MSCs had the doubling time of 34.6 h (Fig. 1D),
which was quite similar to the doubling time of human hAFSCs.
The result of the cell cycle analysis showed that 27.3% of cells
were in the S phase (Fig. 1E). For routine culture, cells were grown
in the 3.5 cm culture plate, and when reached 80% confluence
(0.8610
6 cells/plate), cells in one plate were split into three 3.5 cm
plates (0.25610
6 cells/plate).
Six pAF-MSC cell lines were frozen at passages 8–10. Two cell
lines, which showed the similar cell surface markers of CD117+
and CD44+, were cultured for more than 20 passages. One cell
line was frozen at passage 23 and one cell line, which was used in
this study, was continuously cultured for 60 passages.
Characterization of pAF-MSCs
It has been reported that human AFS cells expressed the surface
antigens including CD117, CD44, CD90, and CD29, but not
CD45 and CD34 [13]. Based on the flow cytometry and RT-PCR
analyses, we found that the pAF-MSCs expressed CD117, CD44,
CD166 (Fig. 2A) and HLA-abc, CD90 (Fig. 2B), but not CD34,
CD45, and CD54 (Fig. 2A, B). The ratio of CD117
+/CD44
+ cells
accounted for 98% of pAF-MSCs population. The immunofluo-
Figure 1. Isolation of pAF-MSCs from the amniotic fluid of E35 porcine fetus. (A) The E35 porcine fetus with whole amniotic membrane.
The amniotic fluid was collected under sterile condition. (B) The morphology of pAF-MSCs after culturing for 3 passages in vitro. Most cells exhibited
fibroblast-like shape. (C) ES cell-likes colony appeared occasionally in the primary pAF-MSCs culture, which was AP staining positive (inset). (D) The
growth curve of the pAF-MSCs (at 6
th passage). The doubling time was 34.6 h. (E) The cell cycle of pAF-MSCs was analyzed by FACS.
doi:10.1371/journal.pone.0019964.g001
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expressed Oct4, Nanog, SSEA4, Tra-1-60 and Tra-1-81, but no
expression of SSEA1, demonstrating that pAF-MSCs had the
similar gene expression profiles as described in human ES cells
(Fig. 2C). These results revealed that the isolated pAF-MSCs
might be at the pluripotent cell transition from the embryonic stem
cell phase to the mesenchymal stem cell phase since pAF-MSCs
expressed both ES and MSC specific markers.
The multi-lineage differentiation of pAF-MSCs
The reports showed that during the formation of embryoid
bodies (EBs) without the treatment with inducers, stem cells were
able to spontaneously differentiate [19]. To determine the
differentiation potential, the pAF-MSCs were grown in suspension
to form EBs (Fig. 3A–B). We then examined the expression of
three embryonic germ layers’ marker in EBs by RT-PCR assay.
The transcriptional expression of FGF5 (a specific marker of
ectoderm), AFP (a specific marker of endoderm) and Bra (a specific
marker of mesoderm) were detectable, indicating that pAF-MSCs
were capable of differentiation in vitro (Fig. 3C). To check the
tumorigenicity of pAF-MSCs, the cells were subcutaneously
injected into three nude mice (BALB/C-nu). One mouse injected
with mES J1 cells was used as the positive control. As shown in
Figure 3D, no teratoma was observed in three mice injected with
pAF-MSCs, but the teratoma appeared in the mouse injected with
mES J1 cells (Fig. 3D). This observation suggested that the pAF-
MSCs, unlike ES cells, didn’t form teratoma and might be much
safer to be used in cell therapeutic application. We also
determined the telomerase reverse transcriptase (TERT) expres-
sion, which is one of essential telomerase components and plays
the key role to maintain the telomere length of the chromosome in
pAF-MSCs. The results showed that TERT solely presented in
pAF-MSC cell nucleus, but was absent in pig embryonic
fibroblasts (PEF, Fig. 3E–F).
Furthermore, to evaluate the multi-lineage differentiation
potential, the pAF-MSCs at the 12
th passage were cultured in
different induction conditions. After incubation with the neuro-
genic differentiation medium, cells differentiated toward neuron-
like cells and expressed neuron specific markers, including Nestin,
NF-200, FGF5 and CD56 (Fig. 4A). With the treatment of
dexamethasone, methylxanthine, insulin and indomethacin, cells
were differentiated into adipocytes that looked like white fat cells
Figure 2. Determination of specific gene markers in pAF-MSCs. (A) The expression of cell surface antigens was examined by flow cytometry.
The antibodies of CD34, CD117 and CD166 were labeled with PE, and CD45, CD44 and CD54 were labeled with FITC. (B) The mRNA expressions of
CD90, CD117 and HLA-abc, but not CD45 were detectable in pAF-MSCs by semi-quantitative RT-PCR assay. The RNA samples were prepared from
pAF-MSCs at 4
th,8
th,1 2
th and 16
th passages. The b-actin was used as internal control. (C) The pluripotent markers of ES cell were determined in pAF-
MSCs (at 6
th passage) by immunofluorescence assay. The antibodies against Oct4, Nanog, SSEA1, SSEA4, Tra-1-60 and Tra-1-81 were conducted and
the positive staining showed green fluorescence (FITC). The nuclei were stained by Hoechst 33342 (blue fluorescence).
doi:10.1371/journal.pone.0019964.g002
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cytoplasm (Fig. 4, B1). The adipocytes were positively stained by
Oil Red O, and expressed adipose specific markers of PPARc and
C/EBPa (Fig. 4, B2-3). When pAF-MSCs were cultured in the
inducing medium that contained Vitamin C and 5-aza, cells were
differentiated towards cardiomyocytes. The cardiac-specific mar-
kers were detected in the differentiated pAF-MSCs, including a-
actin, b-tublin, TNNi3, TbX5, Gata4, a-MHC, MYL and Nkx2.5
(Fig. 4C). These observations indicated that the pAF-MSCs
possessed the multipotency and had the potential to differentiate
into three germ layers in vitro.
The pAF-MSCs differentiate into the beating
cardiomyocytes
The EBs derived from pAF-MSCs expressed cardiac-special
markers, including a-actin, b-tublin, and Nkx2.5 (Fig. 5A). In two-
three weeks induction, the cell masses derived from pAF-MSCs
started to beat rhythmically (Fig. S1, Movie S1, S2). We also tried
the method for directing the commitment of pAF-MSCs from
monolayer to cardiac muscle. Although the beating cells were
observed in some cases, the efficiency of cardiac induction was low
(Fig. S1, Movie S3). We then kept away from this inducing
method. The results of immnuocytochemistry assay showed that
the differentiated cells strongly expressed cardiac specific markers
(a-actin, b-tublin and Nkx2.5), while the undifferentiated pAF-
MSCs only weakly expressed ß-tublin, but not a-actin and Nkx2.5
(Fig. 5B).
To determine the induction efficiency, five differentiation media
were used to induce pAF-MSCs differentiation towards cardio-
myocytes. In the control, the spontaneously differentiated beating
cells were in 5%. With the treatment of either 0.1 mmol/L Vc or
5 mmol/L 5-aza, the beating cell numbers were significantly
increased (Fig. 5C). When the concentration of 5-aza was elevated
to 10 mM, the beating cell numbers were further increased,
suggesting that higher concentration of 5-aza could promote the
differentiation. We also observed that in the combination of
Figure 3. The EBs and teratoma formation. (A) The pAF-MSCs were cultured in suspension at the uncoated Petri dishes for EBs formation. After
24 h of culture EBs were formed and showed positive for alkaline phosphatase (AP) staining (inset). (B) When EBs cultured in the adherent dish for
24 h, the differentiated cells were observed. (C) The expression of three germ layers markers were detected by RT-PCR in the differentiated cells from
EBs. M, DNA marker; Act, b-actin used as an internal control; FGF, Fibroblast growth factor 5 for the primitive ectoderm; AFP, Alpha fetoprotein for the
endoderm; T-Bra, T-box gene brachyury for the mesoderm. (D) The pAF-MSCs (5610
6 cells/injection) were subcutaneously injected into (BALB/c-Nu)
the right axilla of three immunodeficient mice. One mouse injected with mES J1 cells (2610
6 cells/injection) was as positive control. After six weeks
post-injection, three mice injected with pAF-MSCs (on the left) were no teratomas, but mouse injected with mES J1 cells (on the right) showed the
teratoma. (E–F) The TERT expression was detected by anti-TERT antibody in pig embryonic fibroblasts (E) and pAF-MSCs (F).
doi:10.1371/journal.pone.0019964.g003
Isolation and Characterization of pAF-MSCs
PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e199640.1 mM Vc and 5 mM 5-aza percentage of beating cell masses
(33%) was significantly higher than that in the combination of
0.1 mM Vc and 10 mM 5-aza, indicating that Vc might play a key
role in the induction (Fig. 5C). The results of transmission electron
microscope revealed that beating cell masses had the basic
structures of myocardium, such as myofilament and glycogen
granule (Fig. 5D), although the Z line was not yet observed.
Discussion
For prenatal diagnosis, most amniocenteses are performed in
the early week gestation. Within the amniotic fluid are fetal cells
which can be grown in culture for chromosome analysis,
biochemical analysis, and molecular biologic analysis [20]. Gosden
et al. reported that the cells existing in AF were originated from
development embryos, which contained a mixture of multiple cell
types [7,21]. In our study, we found that both epithelial-like and
fibroblast-like cells appeared in the primary porcine AF culture.
After several passages, most cells exhibited fibroblast-like appear-
ance. This might imply that fibroblast-like cells were the dominant
stem cells in AF. Therefore, some researchers named these cells as
AF-mesenchymal stem cells [22]. The specimen from 2–5 ml of
amniotic fluid was enough to generate the primary culture. After
the subculture for 3–4 passages in vitro, the cell numbers could
reach 0.8610
6 per 3.5 cm plate. Over 7 passages, there 2.1610
7
cells were obtained, which were either frozen or used to cellular
experiments. The optimal viability and proliferation of pAF-MSCs
was from 8
th passage till 30
th passage, though one pAF-MSC line
was cultured for more than 60 passages in vitro.
Recently, many reports suggested that hAFS cells were a group
of multipotent stem cells with a great promise in cell therapy and
tissue engineering [7,23]. But so far, very few studies were reported
on porcine AFS. The pAF-MSCs were easy to culture and
expressed specific surface antigens including CD117, CD44,
CD90, CD166 and HLA-abc, but not CD45, CD34 and CD54.
The most gene expression profiles of pAF-MSCs were similar to
hAFS cells [4]. However, the expressions of Tra-1-60 and Tra-1-
81 were not found in hAFSCs [24], while pAF-MSCs expressed
both Tra-1-60 and Tra-1-81 markers. These differences might be
caused by the species difference since we did find the sub-group of
cell population with CD1172/CD44+ and CD117+/CD44+ in
human amniotic fluid stem cells (unpublished data). The results to
monitor the expression of CD90 and CD117, the mesenchymal
stromal cell markers, in the different passages showed that these
markers were constantly expressed in pAF-MSCs, although the
expression levels were slightly decreased in later passages (Fig. 2B).
Thus, these two genes plus CD44 could be used as the pAF-MSCs
markers. Besides, the hematopoietic cell marker CD45 and CD34
were not detected in pAF-MSCs, suggesting that pAF-MSCs did
not come from the hematopoietic cell derivative. Additionally,
pAF-MSCs expressed the transcription factors Oct4, Nanog and
cell surface marker SSEA4, which were the important regulators
for maintaining the pluripotent state in mES and hES cells
[25,26,27,28]. The above features indicated that the pAF-MSCs
Figure 4. The multi-lineage differentiation potential of pAF-MSCs in vitro. The specific markers were detected by immunocytochemistry
(ICC) and RT-PCR. (A) The pAF-MSCs differentiated into neurocytes. (1) ICC of Nestin; (2) ICC of NF-200; (3) RT-PCR assay for FGF5 and CD56. (B) The
pAF-MSCs differentiated into adipocytes. (1) The lipocytes were induced for two weeks. The lipid droplets were round the nuclei (inset); (2) The cells
were positive for Oil Red O staining; (3) RT-PCR assay for PPARc and C/EBPa in adipocyte derived from pAF-MSCs. (C) The pAF-MSCs differentiated
into cardiomyocytes. (1) ICC of a-actin; (2) ICC of ß-tublin; (3) RT-PCR assay for cardiomyocyte specific markers including Tbx5, Gata4, a-MHC, TNNi3,
MYL and Nkx2.5. Act, b-actin was used as the internal control; M, DNA marker.
doi:10.1371/journal.pone.0019964.g004
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lineage-restricted adult stem cells.
It was reported that the stem cells isolated from porcine AF had
the ability of neurogenic differentiation [29]. However, the ability
to differentiate into cardiogenic phenotypes in an autotransplanted
model of cardiac ischemia was not achieved [30]. In this study, the
pAF-MSCs could express markers of three germ layers and
differentiate into myocardial cell mass. Under the treatment of Vc
and 5-aza, cell mass from pAF-MSCs could beat rhythmically,
symbolizing the cardiac muscle. More experiments are needed to
determine if these beating cells can be used for the therapy of
cardiac ischemia in pig model. The embryoid body formation
mimics the earliest stages of embryonic development. Many
protocols of embryonic stem cell differentiation have been
reported to depend on EBs to initiate the spontaneous differen-
tiation that occurs within 3-dimensional aggregates [19]. In the
beginning experiments, we have tried both EB and monolayer
methods to induce pAF-MSCs into cardiomyocytes. The result
indicated that the induction efficiency by monolayer method was
low, and the induced products were difficult to characterize due to
the less beating cell population.
One merit of hAFSCs was their non-tumorigenesis, which was
different from hES cells [7]. In our experiment, we also confirmed
that the injection of pAF-MSCs into the immunodeficient mice
didn’t generate tumors. This result suggested that pAF-MSCs cells
were the valuable seeded cells that could be used for the transgenic
animals and as the recipient cells for gene knockout.
In conclusion, we successfully isolated and characterized pAF-
MSCs from porcine amniotic fluid. They possessed self-renewal
and multi-lineage differentiation potency, which could differenti-
ate into neuroncytes, adipocytes and myocardial cell mass. The
pAF-MSCs would provide an ideal cell resource for regenerative
Figure 5. The pAF-MSCs differentiated into beating cardiomyocytes in vitro. (A) The EBs cultured in suspension with cardiac differentiation
medium for 17 day expressed cardiomyocyte special markers, including a-actin, b-tublin and Nkx2.5. (B) The pAF-MSCs continually grew in
cardiomyogenic medium for 17 days in the tissue culture plate to induce the differentiation into cardiomyocytes. The immunofluorescence analysis
was conducted to determine a-actin, ß-tublin and Nkx2.5 expression in the uninduced pAF-MSCs (0 d) and the induced pAF-MSCs (17 d). (C) The
percentage of beating cell masses induced by the different media was counted. * indicates difference at p,0.05; ** indicates significant difference at
p,0.01. (D) Transmission electron microscope analysis of the beating cell masses. 1, pig heart tissue was used as the control. The arrows indicate the
Z lines (625 k); 2, the cardiac-muscle like filament from the beating cell masses derived from pAF-MSCs. The arrows indicated the glycogen pool and
glycogen granules (630 k). 3, the cardiac-muscle like structure was observed in the beating cell masses (612 k). 4, The enlarged photo showed the
cell connections (arrows) (650 k).
doi:10.1371/journal.pone.0019964.g005
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mechanisms involved in the self-renewal and multipotency of
pAF-MSCs remains unclear and need to be further investigated.
Materials and Methods
Isolation and growth of pAF-MSCs
The pig amniotic fluid (2–5 ml) was collected from the amniotic
cavity of pregnant crossbred gilt in the early stage of gestation (at
E35) and centrifuged at 400 g for 5 min. After three times washing
with PBS, the cells were gently suspended and plated in 6-well
culture plate (Costar) with pAF-MSC medium (AMM), including
a-MEM medium (Invitrogen, all the reagents used without
emphasized were from Invitrogen.), 15% FBS, 1% glutamine
and 1% penicillin/streptomycin, at 38uCi n5 %C O 2 incubator.
After 3 days growth, both fibroblast-like cells and epithelioid cells
appeared and formed cell clusters. The epithelioid cells were
removed by Tissue Cell Scraper, and fibroblast-like cell clusters
were sub-cultured in new 12-well plates (Costar). This process was
repeated twice. Finally, the uniform fibroblast-like cells were
cultured in 3.5 cm culture plate. When reached 80% confluence
(0.8610
6 cells/plate), cells were treated with 0.05% Trypsin-
EDTA and passaged every two days with a 1:3 split. To determine
the growth rate of cells, the pAF-MSCs at 6
th passages were plated
at 4610
3 in each well of the 24-well plate and cultured for 8 days.
Cells in every three wells were collected from day 1 to day 8 and
counted using a hemocytometer. The average cell numbers for
each three wells were calculated and the growth curve was plotted
with the average number of cells at different times.
Flow cytometry analysis
The DNA content and surface antigens of pAF-MSCs were
examined by flow cytometry analyses. To detect DNA content,
cells were harvested by the treatment of Trypsin and fixed in 70%
ethanol. After incubation in an ice-bath for 30 min, the cells were
washed three times with washing buffer (PBS with 1% BSA and
0.05% NaN3), and then resuspended in 20 ml of washing buffer
and 10 ml of Propidium Iodide (PI) solution (stock solution
10 mg/ml). Approximately 1610
6 cells/ml were used for the flow
cytometry cell sorting (Beckman Coulter). To determine the
surface antigens of pAF-MSC, cells were trypsinized and stained
with fluorescein isothiocyanate (FITC)-conjugated or phycoery-
thrin-conjugated antibodies against CD117 (559879#, BD, USA),
CD34 (555823#, BD, USA), CD166 (Santa, USA), CD54 (Santa,
USA), CD44 (555478#, BD, USA), and CD45 (555482#, BD,
USA). The cells were then analyzed by flow cytometry (Becton
Coulter).
Total RNA extraction and RT-PCR
Total RNA of pAF-MSCs was extracted using Trizol reagent
according to the manufacturer’s instruction, and high quality
RNA (OD260/280=2.0) was used for the reverse transcription
reaction. RT-PCR was performed according to a coupled one-
step procedure using Access RT-PCR System (Promega,
Madison WI, USA). Briefly, 2 mg of total RNA was reverse
transcribed at 37uC for 1 h, denatured at 94uCf o r2m i n ,a n d
amplified for 30 cycles of denaturation at 94uCf o r3 0 s e c ,
primer annealing at 55uC for 30 sec, and extension at 72uCf o r
45 sec, followed by a final extension step at 72uC for 10 min.
The amplified products were analyzed by electrophoresis on 1%
agarose gel. Images were taken with a High Performance CCD
camera. The primers used in this experiment were listed in
Table 1.
Immunocytochemistry
The cells were grown at 37uC in a humidified CO2 incubator
until they were 60–70% confluent, and were then fixed in 4%
paraformaldehyde solution and blocked with 5% bovine serum
albumin (BSA) for 1 h. The blocked cells were incubated with
primary antibody at a dilution of 1:100 at 4uC overnight. After
three times washing, the secondary antibody conjugated with
either FITC or TRITC was added, respectively, at a dilution of
1:100 in PBS for 1 h at 37uC. Nuclei were stained with Hoechst
33342 (10 ug/ml) for 1 min and viewed under a laser scanning
Confocal microscope (Leica, Heidelberg, Germany). In some
experiments, biotinylated secondary antibodies and an avidin-
biotinylated enzyme complex system (Vectastain Elite ABC Kits)
with a DAB substrate kit (Vector Laboratories) were used to
visualize positive cells. For negative control, parallel experiments
Table 1. Primer sequences for RT-PCR.
Primer Sequences, 59 to 39 Size (bp)
Accession
number
b-actin S: TACGACTGGCATTGTGC 360 EU655628
A: TACGACTGGCATTGTGC
CD117 S: ACCGCACTGCCACTGAT 427 NM_001044525
A: TAAGCCCTGCACTCCAC
CD90 S: GACCCGTGAGACAAAGCAGC 171 DQ400919
A: TGGCCAGAGTGGTGGAGTTC
CD45 S: CCTCCAGATCCTACAAA 443 AY444867
A: CCATCACTCCGATAACA
CD56 S: GAGGGGGAAGATGCCGTGATGTG 269 NC_006587.2
A: ATATTCTGCCTGGCCCGGATGGTAG
AFP S: GGAGAAATGTTCGCAGTC 306 NM_214317.1
A: TGCCCGATGATAAGGT
Bra S: AAGAACGGCAGGAGGATGG 372 XM_001928144.1
A: CTCTGGGAAGCAGTGGC
FGF5 S: TCACGGGGAGAAGCGTCT 407 NM_004464.3
A: ACTTGGCACTTGCATGGA
HLA-abc S: GTATTTCTTCACATCCGTGTCCCG 394 M27971.1
A: GTCCGCCGCGGTCCAAGAGCGCAG
PPARc S: GATGCCACAGGCCGAGAAGG 235 NC_000003.10
A: GCCCTGAAAGATGCGGATGG
C/EBPa S: CCCCGCGAGGAGGATGAAGC 126 NC_000019.8
A: GCACCCGGTACTCGTTGCTGTTCT
TbX5 S: ATTGCTGAAACCGAGAATGG 250 AM937230.1
A: GCGCTCCTTGAGGTTGAAAAG
Gata4 S: CTGTGCCAACTGCCAGACCA 437 NM_214293.1
A: GGCTGACCGAAGATGCGTAG
a-MHC S: AGAAGATAGTGGAACGCAG 147 NC_000014.8
A: GCATCATTGAGGTTGTCTTG
TNNi3 S: GAGTGAGGATCTCTGCAGAT 130 NM_000363
A: GATGTTCTTGCGCCAGTCTC
MYL S: CTCCAACGTGTTCTCCATG 272 NM_000432
A: CCTTGAATGCGTTGAGAATG
NKX2.5 S: CATGCTGGCCGCCTTCAAG 438 NM_004387
A: CCAGATCTTGACCTGCGTG
doi:10.1371/journal.pone.0019964.t001
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corresponding animal. The primary antibodies used in this
experiment were as below: anti-Oct4 (ab13840, Abcam, UK),
anti-Nanog (ab21603, Abcam, UK), anti-SSEA1 (90230, Millipore,
USA), anti-SSEA4 (90231, Millipore, USA), anti-Tra-1-60 (90232,
Millipore, USA), anti-Tra-1-81 (90233, Millipore, USA), anti-NF-
200 (ab82259, Abcam, UK), anti-Nestin (MAB5326, Chemicon),
anti-TERT (sc-7212, Santa Cruz, UAS), anti-a-actin (A2172,
Sigma, USA), anti-b-tublin (bs-0210R, Beijing Biosynthesis Bio-
technology Co, LTD, China ), anti-Nkx2.5 (ab97355, Abcam, UK).
Embryoid bodies and Teratoma formation
The pAF-MSCs at the 12
th passage were harvested with 0.05%
Trypsin and reseeded in the ultra-low binding dish with a
concentration of 1610
6 cells/ml. During the 24 h incubation in
the suspension culture, embryoid bodies (EBs) were formed, and
continuously grew for 2–3 days allowing to form bigger and even
EBs. To detect alkaline phosphatase activity, the EBs from pAF-
MSCs were fixed with 4% paraformaldehyde for 10 min at room
temperature, washing twice with ice-cold PBS, EBs were then
incubated with Fast Red TR/Naphthol AS-MX Phosphate (Fast
Red TR 1.0 mg/ml, Naphthol AS-MX 0.4 mg/ml, in 0.1 M Tris
Buffer) for 20–30 min at room temperature. A red color stain
indicated the positive reaction for alkaline phosphatase. The
images were photographed by Leica 1300 digital CCD camera
(Roper Industries, Duluth, GA).
The teratoma formation assays with pAF-MSCs were conduct-
ed in Animal Center of the Fourth Military Medical University,
which was the licensed animal research facility and provides the
commercial services. The pAF-MSCs (5610
6 cells/injection) were
subcutaneously injected into the right axilla of three immunode-
ficient mice (BALB/c-Nu). One mouse injected with mES J1 cells
(2610
6 cells/injection) was a positive control. The mice breeding
and cell injection experiments were carried out by Fourth Military
Medical University in Xi’an, Shaanxi, China. Post-injection for 45
days, the teratoma tissue was collected, and used for the
histochemistry assay and RNA extraction.
Differentiation of pAF-MSCs into three germ layer
lineages
To induce pAF-MSCs into three germ layer lineages, cells at the
12
th passage were harvested with 0.05% Trypsin and reseeded in
ultra-low binding dish with a concentration of 1610
6 cells/ml to
form EBs for 3 days. The EBs were then transferred to gelatin-
coated dishes to attach, and grew in the induction media to induce
cell differentiation. After the induction, the tissue specific gene
markers were then examined to define the progression of the
differentiation by the immunocytochemy (ICC) and RT-PCR
analysis. To perform adipogenic differentiation, EBs were cultured
in adipogenic differentiation medium (a-MEM supplemented with
1 mM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine
(IBMX), 1.7 mM insulin, and 0.2 mM indomethacin) for two
weeks, changing medium every 2–3 days. Oil Red O staining was
used to detect adipocytes. To perform neurogenic differentiation,
cells were cultured in neurogenic differentiation medium (a-MEM
supplemented with 20% FBS, 1 mmol/l b-mercaptoethanol,
5 ng/ml bFGF) for 24 h, and then treated with serum depletion
medium for 5 h. The neuron specific markers of Nestin, NF-200,
FGF5 and CD56 were examined. After the cytochemistry
determination, the images were photographed by Leica 1300
digital CCD camera (Roper Industries, Duluth, GA).
To perform cardiac differentiation, we made five different media,
whichincluded1# AMM+0.1 mMVc;2# AMM+5 mM5- a za ;3#
AMM+10 mM 5-aza; 4# AMM+0.1 mM Vc+5 mM 5-aza; and 5#
AMM+0.1 mM Vc+10 mM 5-aza. The control medium was AMM.
To differentiate pAF-MSCs into beating cardiomyocytes, cells were
culturedinsuspensioninAMMfor5daystoformEBs,andthenEBs
were pelleted and resuspended in media 1#–5#, respectively, and
continually grew in suspension for 2 days. After total 7 day in
suspension, cells were transferred into 48-well tissue culture plate
allowing EBs to attach the plate surface, and grew in fresh AMM for
10 days, changing medium in every 2–3 days, to induce the beating
cardiomyocytes. The percentage of beating cell masses was counted.
The experiments were repeated separately for 3 times. The
differentiation efficiency was compared via statistical analysis where
p,0.05 was considered statistical significant. To perform the
immunocytochemistry assay, the beating cell masses were treated
with 0.05% Trypsin, reseeded on a new plate for 12 h, and then ran
the assay described above. To conduct the histochemistry analysis,
therhythmicallybeatingcellmasseswerepickedoutandfixedby3%
glutaraldehyde. The transmission electron microscopy analysis was
carried out by the Central Laboratory of Fourth Military Medical
University (Xi’an, Shaanxi, China).
Supporting Information
Figure S1 The beating cardiomyocyte-like cell clusters
differentiated from pAF-MSCs. (A) The fast beating cell
mass. The rate of beating frequency was in the range of 90–110
beats/min. (B) The slow beating cell mass. The rate of beating
frequency was in the range of 25–50 beats/min. (C) The
monolayer beating cells.
(TIF)
Movie S1 The fast beating cell mass.
(MP4)
Movie S2 The slow beating cell mass.
(MP4)
Movie S3 The monolayer beating cells.
(MP4)
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